Search research articles
Contact Us
Filters
Showing results (81-90 of 148) with videos related to
Page
of 15
Sort By:
Cancer Medicine
|
November 14, 2023
A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia
Aref Al-Kali, Ibrahim Aldoss, Pamela J Atherton, et al.
Blood Cancer Journal
|
September 22, 2023
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity
Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, et al.
British Journal of Haematology
|
March 5, 2025
Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome
Yael Kusne, Talha Badar, Terra Lasho, et al.
Blood Advances
|
October 13, 2021
Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms
Hassan B Alkhateeb, Ahmad Nanaa, David Viswanatha, et al.
Leukemia & Lymphoma
|
October 3, 2018
Elderly acute lymphoblastic leukemia: a Mayo Clinic study of 124 patients
Kevin C Miller, Aref Al-Kali, Mithun V Shah, et al.
Haematologica
|
May 18, 2023
Clinical and molecular correlates of somatic and germline <i>DDX41</i> variants in patients and families with myeloid neoplasms
Talha Badar, Ahmad Nanaa, James M Foran, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 1, 2019
Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis
Rong He, Daniel J Devine, Zheng Jin Tu, et al.
Blood Neoplasia
|
April 6, 2026
Treatment-specific prognostic performance of ELN 2022, ELN 2024, and Beat AML 2024: a real-world AML validation study
Tariq Kewan, Oudai Alkabbani, Hadil Zureigat, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 9, 2019
Correction to: Hybridization capture-based next-generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis
Rong He, Daniel J Devine, Zheng Jin Tu, et al.
Leukemia & Lymphoma
|
November 6, 2024
Clinical outcomes of patients diagnosed with <i>SETBP1</i> mutated myeloid neoplasms
Yazan Jabban, Mahmoud Yacout, Anmol Baranwal, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 148) with videos related to
Sort By:
Page
of 15
Cancer Medicine
|
November 14, 2023
A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia
Aref Al-Kali, Ibrahim Aldoss, Pamela J Atherton, et al.
Blood Cancer Journal
|
September 22, 2023
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity
Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, et al.
British Journal of Haematology
|
March 5, 2025
Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome
Yael Kusne, Talha Badar, Terra Lasho, et al.
Blood Advances
|
October 13, 2021
Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms
Hassan B Alkhateeb, Ahmad Nanaa, David Viswanatha, et al.
Leukemia & Lymphoma
|
October 3, 2018
Elderly acute lymphoblastic leukemia: a Mayo Clinic study of 124 patients
Kevin C Miller, Aref Al-Kali, Mithun V Shah, et al.
Haematologica
|
May 18, 2023
Clinical and molecular correlates of somatic and germline <i>DDX41</i> variants in patients and families with myeloid neoplasms
Talha Badar, Ahmad Nanaa, James M Foran, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 1, 2019
Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis
Rong He, Daniel J Devine, Zheng Jin Tu, et al.
Blood Neoplasia
|
April 6, 2026
Treatment-specific prognostic performance of ELN 2022, ELN 2024, and Beat AML 2024: a real-world AML validation study
Tariq Kewan, Oudai Alkabbani, Hadil Zureigat, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 9, 2019
Correction to: Hybridization capture-based next-generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis
Rong He, Daniel J Devine, Zheng Jin Tu, et al.
Leukemia & Lymphoma
|
November 6, 2024
Clinical outcomes of patients diagnosed with <i>SETBP1</i> mutated myeloid neoplasms
Yazan Jabban, Mahmoud Yacout, Anmol Baranwal, et al.
Page
of 15